Sunday, January 18, 2026 | 09:53 AM ISTहिंदी में पढें
Zydus Lifesciences Ltd
Announcement under Regulation 30 (LODR)-Press Release / Media Release
06:28 PM, 23rd Dec 2025
Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO an Interchangeable Biosimilar to Lucentis. NUFYMCO BLA has been approved by the USFDA.